Wolfe Research initiates X-Energy stock with Peerperform rating By Investing.com

Wolfe Research initiated coverage on X-Energy with a Peerperform rating and a fair value range of $27 to $37 versus a current price of $25.60, implying limited near-term upside. The company is targeting 40% to 45% overall margins and expects EBITDA and free cash flow neutrality around 2030, but it still posted a negative 71% gross margin on $94 million of revenue over the last 12 months. Analyst views remain mixed, with recent targets ranging from $28 to $57 as the company works toward first reactor deployment and regulatory approvals.

Analysis

The market is still pricing X-Energy like a pre-commercial science project, but the more interesting angle is the option value embedded in its contract structure. If the company can keep a large share of revenue recurring post-COD, the business starts to resemble a long-duration infrastructure annuity rather than a one-time reactor vendor, which deserves a materially higher multiple than today’s asset-light development comps. The problem is timing: the valuation debate is likely to stay disconnected from fundamentals for at least 24-36 months because the first real de-risking event is regulatory, not financial.

The bigger second-order winner is AMZN, not because it owns equity, but because power availability is becoming a strategic bottleneck for AI infrastructure. A successful nuclear development path gives hyperscalers a hedge against grid congestion, interconnection delays, and renewable intermittency; that optionality is valuable even if the initial project economics are mediocre. Dow is effectively getting a financed industrial decarbonization asset, but the real spread trade is that downstream users of firm clean power could re-rate if small modular reactors prove bankable.

The bear case is execution slippage: every additional quarter of permitting delay pushes cash flow break-even farther out and increases the probability that financing terms tighten before the first plant reaches construction visibility. The market is probably underestimating how sensitive the thesis is to NRC process risk and cost inflation; if either worsens, the implied 2030s cash generation window can slide enough to compress fair value back toward the low end of analyst ranges. Conversely, any construction permit milestone or a second anchor customer can reset expectations quickly because the stock has already de-rated sharply and is trading near technical support.

Key Decisions for Investors

• Long AMZN vs short a basket of grid-constrained AI infrastructure names over 6-12 months; if nuclear capacity becomes a credible power solution, AMZN gets strategic optionality while peers remain exposed to load-shedding and interconnect delays.
• Initiate a speculative long in XE only on regulatory pullbacks, not strength; use a 6-18 month horizon with a tight stop below recent lows because the stock’s upside is contingent on permit milestones, not near-term earnings.
• Pair trade: long XE / short a high-duration unprofitable clean-tech developer basket for 12 months; if advanced nuclear keeps gaining institutional sponsorship, capital should rotate away from less differentiated project-risk stories.
• Buy downside protection on XE into any pre-permit rally via put spreads; the best risk/reward is to own convexity because a single delay headline can reprice the equity more than incremental optimism can lift it.
• Watch DOW for a relative-strength setup on any nuclear-policy catalyst; if the project remains on track, Dow could quietly gain the most as a first-mover industrial decarbonization beneficiary with limited direct execution risk.